Skip to main navigation
Skip to search
Skip to main content
WashU Medicine Research Profiles Home
Help & FAQ
Home
Profiles
Departments, Divisions and Centers
Research output
Search by expertise, name or affiliation
Stereotactic body radiation therapy (SBRT) for hepatocellular carcinoma
Brian C. Baumann
, Jenny Wei
, John P. Plastaras
, John N. Lukens
, Nevena Damjanov
, Maarouf Hoteit
, Christine Hsu
, Matthew Levine
, Jeffrey Mondschein
, Gregory Nadolski
, Kim Olthoff
, Kim A. Reiss
, Mark Rosen
, Evan Siegelman
, James M. Metz
, Edgar Ben-Josef
Siteman Cancer Center
Division of Clinical Research
Research output
:
Contribution to journal
›
Article
›
peer-review
43
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Stereotactic body radiation therapy (SBRT) for hepatocellular carcinoma'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Hepatocellular Carcinoma
100%
Stereotactic Body Radiation Therapy
100%
Local Control
44%
Liver-directed Therapy
33%
Solitary Lesion
22%
Hepatic Toxicity
22%
Advanced Cirrhosis
22%
Liver
11%
Magnetic Resonance Imaging
11%
Overall Survival
11%
Linear Accelerator (LINAC)
11%
Ascites
11%
Curative Treatment
11%
Gastrointestinal Bleeding
11%
Local Failure
11%
Fiducial Markers
11%
Radiofrequency Ablation
11%
Breath-hold
11%
Transarterial Chemoembolization
11%
Stereotactic Body Radiotherapy
11%
Capsular
11%
Hepatocellular Carcinoma Patients
11%
Child-Pugh B
11%
Child-Pugh
11%
Huge Hepatocellular Carcinoma
11%
4D Computed Tomography
11%
Large Lesions
11%
Liver-directed Treatment
11%
Small Hepatocellular Carcinoma
11%
Lesion Diameter
11%
Medicine and Dentistry
Hepatocellular Carcinoma
100%
Stereotactic Body Radiation Therapy
100%
Liver Cirrhosis
20%
Hepatic Toxicity
20%
Magnetic Resonance Imaging
10%
Overall Survival
10%
Prospective Study
10%
Breathing
10%
Transcatheter Arterial Chemoembolization
10%
Four Dimensional Computed Tomography
10%
Radiofrequency Ablation
10%
Carbon 11
10%
Ascites
10%
Ciclonicate
10%
Fiducial Marker
10%